Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common stock
-
Shares outstanding
-
47.1M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
12.2M
-
Shares change
-
+1.08M
-
Total reported value, excl. options
-
$294M
-
Value change
-
+$23.9M
-
Number of buys
-
26
-
Number of sells
-
-10
-
Price
-
$24.15
Significant Holders of Whitehawk Therapeutics, Inc. - Common stock (WHWK) as of Q4 2021
47 filings reported holding WHWK - Whitehawk Therapeutics, Inc. - Common stock as of Q4 2021.
Whitehawk Therapeutics, Inc. - Common stock (WHWK) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.2M shares
of 47.1M outstanding shares and own 25.84% of the company stock.
Largest 10 shareholders include Avoro Capital Advisors LLC (1.83M shares), VR Adviser, LLC (1.53M shares), ACUTA CAPITAL PARTNERS, LLC (1.53M shares), Vivo Capital, LLC (1.3M shares), BVF INC/IL (899K shares), RTW INVESTMENTS, LP (765K shares), VANGUARD GROUP INC (761K shares), Rock Springs Capital Management LP (539K shares), PRICE T ROWE ASSOCIATES INC /MD/ (509K shares), and SATTER MANAGEMENT CO., L.P. (375K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.